Literature DB >> 11592888

[2+2] versus [3+2] addition of metal oxides across C=C double bonds: toward an understanding of the surprising chemo- and periselectivity of transition-metal-oxide additions to ketene.

D V Deubel1, S Schlecht, G Frenking.   

Abstract

The peri-, chemo-, stereo-, and regioselectivity of the addition of the transition-metal oxides OsO4 and LReO3 (L = O-, H3PN, Me, Cp) to ketene were systematically investigated using density-functional methods. While metal-oxide additions to ethylene have recently been reported to follow a [3+2] mechanism only, the calculations reveal a strong influence of the metal on the periselectivity of the ketene addition: OsO4 again prefers a [3+2] pathway across the C=C moiety whereas, for the rhenium oxides LReO3, the [2+2] barriers are lowest. Furthermore, a divergent chemoselectivity arising from the ligand L was found: ReO4- and (H3PN)ReO3 add across the C=O bond while MeReO3 and CpReO3 favor the addition across the C=C moiety. The calculated energy profile for the MeReO3 additions differs from the CpReO3 energy profile by up to 45 kcal/mol due to the stereoelectronic flexibility of the Cp ligand adopting eta5, eta3, and eta1 bonding modes. The selectivity of the cycloadditions was rationalized by the analysis of donor-acceptor interactions in the transition states. In contrast, metal-oxide additions to diphenylketene probably follow a different mechanism: We give theoretical evidence for a zwitterionic intermediate that is formed by nucleophilic attack at the carbonyl moiety and undergoes a subsequent cyclization yielding the thermodynamically favored product. This two-step pathway is in agreement with the results of recent experimental work.

Entities:  

Year:  2001        PMID: 11592888     DOI: 10.1021/ja003733s

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  1 in total

1.  A computational study of the addition of ReO3L (L = Cl(-), CH3, OCH3 and Cp) to ethenone.

Authors:  Albert Aniagyei; Richard Tia; Evans Adei
Journal:  Springerplus       Date:  2016-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.